Cases of intracranial hemorrhage and an increased risk of postpartum hypertension due to drug-induced hypertension have been reported for prolactin inhibitors (bromocriptine, cabergoline) (Watson et al., 1989; Kirsch et al., 2001). Here, PRL is linked to intracranial hemorrhage.